Investment analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Price Performance
Shares of NASDAQ:RKDA opened at $6.15 on Wednesday. The company’s 50-day moving average price is $4.36 and its two-hundred day moving average price is $3.41. Arcadia Biosciences has a one year low of $1.85 and a one year high of $10.31. The stock has a market capitalization of $8.39 million, a PE ratio of -1.44 and a beta of 1.19.
About Arcadia Biosciences
Read More
- Five stocks we like better than Arcadia Biosciences
- About the Markup Calculator
- Top 3 Investment Themes to Watch for in 2025
- Top Biotech Stocks: Exploring Innovation Opportunities
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.